164 related articles for article (PubMed ID: 1589712)
1. Bismuth absorption from 205Bi-labelled pharmaceutical bismuth compounds used in the treatment of peptic ulcer disease.
Dresow B; Fischer R; Gabbe EE; Wendel J; Heinrich HC
Scand J Gastroenterol; 1992 Apr; 27(4):333-6. PubMed ID: 1589712
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of bismuth from 205Bi-labelled pharmaceutical oral Bi-preparations in rats.
Dresow B; Nielsen P; Fischer R; Wendel J; Gabbe EE; Heinrich HC
Arch Toxicol; 1991; 65(8):646-50. PubMed ID: 1747063
[TBL] [Abstract][Full Text] [Related]
3. Absorption of bismuth from two bismuth compounds before and after healing of peptic ulcers.
Hundal O; Bergseth M; Gharehnia B; Andersen KJ; Berstad A
Hepatogastroenterology; 1999; 46(29):2882-6. PubMed ID: 10576366
[TBL] [Abstract][Full Text] [Related]
4. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
Wagstaff AJ; Benfield P; Monk JP
Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124
[TBL] [Abstract][Full Text] [Related]
5. Colloidal bismuth subcitrate in peptic ulcer disease.
Tytgat GN
S Afr Med J; 1986 Jul; 70(1):31-3. PubMed ID: 3523793
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
7. Hepatic and cerebrospinal fluid accumulation of aluminium and bismuth in volunteers taking short course anti-ulcer therapy.
Gane E; Sutton MM; Pybus J; Hamilton I
J Gastroenterol Hepatol; 1996 Oct; 11(10):911-5. PubMed ID: 8912126
[TBL] [Abstract][Full Text] [Related]
8. [Tripotassium-dicitrato bismuthate in the treatment of peptic ulcer and the prevention of its recurrence].
Gibiński K; Nowak A; Marlicz K; Depczyńska A; Dzieniszewski J; Milewski B; Gabryelewicz A; Kosidło S
Pol Tyg Lek; 1984 Nov; 39(47):1547-50. PubMed ID: 6393096
[No Abstract] [Full Text] [Related]
9. Bismuth compounds in the treatment of peptic ulcer: a review.
Nanivadekar SA
J Assoc Physicians India; 1990 Sep; 38 Suppl 1():736-42. PubMed ID: 2092031
[No Abstract] [Full Text] [Related]
10. [Effect of meals on resorption of bismuth from an oral bismuth gallate/bismuth nitrate preparation].
Leonhardt H; Klotz U
Med Klin (Munich); 1991 Apr; 86(4):194-7. PubMed ID: 2056984
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of the efficacy of de-nol and bismuth subnitrate treatment of patients with associated peptic ulcer and pyloric Helicobacter infection (experimental and clinical studies)].
Il'chenko AA; Zurabishvili NG; Zhukhovitskiĭ BG; Gorodinskaia VS
Ter Arkh; 1991; 63(2):21-6. PubMed ID: 2048016
[TBL] [Abstract][Full Text] [Related]
12. Double blind randomised study of tripotassium-di-citrato-bismuthate in the treatment of peptic ulcer.
Tripathi BM; Misra NP; Dube S
J Assoc Physicians India; 1984 Nov; 32(11):964-5. PubMed ID: 6396295
[No Abstract] [Full Text] [Related]
13. [Absorption and renal elimination of bismuth from 6 different bismuth salts after a single dosage].
Heckers H; Mannl MR; Muskat E; Stelz A; Bödeker RH
Z Gastroenterol; 1994 Jul; 32(7):375-81. PubMed ID: 7975772
[TBL] [Abstract][Full Text] [Related]
14. A study relating to bioavailability and renal elimination of bismuth after oral administration of basic bismuth nitrate.
Behrendt WA; Gröger C; Kuhn D; Schulz HU; Topfmeier P
Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):357-60. PubMed ID: 1937997
[TBL] [Abstract][Full Text] [Related]
15. Colloidal bismuth subcitrate in peptic ulcer--a review.
Tytgat GN
Digestion; 1987; 37 Suppl 2():31-41. PubMed ID: 3305117
[TBL] [Abstract][Full Text] [Related]
16. [Selective and locally-acting drugs in the treatment of peptic ulcer].
Ryss ES
Klin Med (Mosk); 1984 Jul; 62(7):10-8. PubMed ID: 6384654
[No Abstract] [Full Text] [Related]
17. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate.
Bianchi Porro G; Parente F
J Clin Gastroenterol; 1992 Apr; 14(3):192-8. PubMed ID: 1348753
[TBL] [Abstract][Full Text] [Related]
18. Bismuth absorption from the colloidal subcitrate.
Hespe W; Staal HJ; Hall DW
Lancet; 1988 Nov; 2(8622):1258. PubMed ID: 2903993
[No Abstract] [Full Text] [Related]
19. Sucralfate and other non-antisecretory agents in the treatment of peptic ulcer disease.
May B
Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():113-6. PubMed ID: 2657280
[TBL] [Abstract][Full Text] [Related]
20. Present and future treatment of peptic ulcer and potential role of DE-NOL.
Scand J Gastroenterol Suppl; 1982; 80():49-57. PubMed ID: 6761852
[No Abstract] [Full Text] [Related]
[Next] [New Search]
